Cervical cancer screening among low-income women: Results of a national screening program, 1991-1995

Obstetrics and Gynecology

Volumn 92, Issue 5, 1998, Pages 745-752

  Lawson, Herschel W ^a   Lee, Nancy C ^a   Thames, Sandra F ^a   Henson, Rosemarie ^a   Miller, Daniel S ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MASS SCREENING; PAPANICOLAOU TEST; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POVERTY; PREDICTIVE VALUE OF TESTS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0031791893     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00257-9     Document Type: Article

References (36)

1. American Cancer Society. Cancer facts & figures - 1997. Atlanta, Georgia: American Cancer Society, 1997.
2. Herrero R. Epidemiology of cervical cancer. Monogr Natl Cancer Inst. 21:1996;1-6.
3. Kurman R.J., Henson D.E., Herbst A.L., Noller K.L., Schiffman M.H. Interim guidelines for management of abnormal cervical cytology. JAMA. 271:1994;1866-1869.
4. Shingleton H.M., Patrick R.L., Johnson W.W., Smith R.A. The current status of the Papanicolaou smear. CA Cancer J Clin. 45:1995;305-320.
5. Anderson L.M., May D.S. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 85:1995;840-842.
6. Blackman DK, Bennet EM, Miller DS. Trends in mammogram and Papanicolaou test utilization, 1989-1994. MMWR CDC Surveill Summ. In press.
7. Henson R.M., Wyatt S.W., Lee N.C. The National Breast and Cervical Cancer Early Detection Program A comprehensive public health response to two major health issues for women . J Public Health Manage. 2:1996;36-47.
8. May D.S., Lee N.C., Nadel M.R., Henson R.M., Miller D.S. The National Breast and Cervical Cancer Early Detection Program Report on the first four years of mammography provided to medically underserved women . AJR Am J Roentgenol. 170:1998;97-104.
9. Kurman R.J., Solomon D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. 1993;Springer-Verlag, New York.
10. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment of gynecological cancer. Vol 20. Stockholm: International Federation of Gynecology and Obstetrics, 1988.
11. U.S. Department of Health and Human Services. Summary staging guide for the cancer Surveillance, Epidemiology and End Results (SEER) reporting system. NIH publication no. 86-2313. Bethesda, Maryland: National Institutes of Health, 1986:115-6.
12. Freund J.E., Smith R.M. Statistics A first course . 4th ed. 1986;363 Prentice-Hall, Englewood Cliffs, New Jersey.
13. Sadeghi S.B., Hsieh E.W., Gunn S.W. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults; results of data analysis of mass Papanicolaou screening of 796,337 women in the United States in 1981. Am J Obstet Gynecol. 148:1984;726-729.
14. Boyes D.A., Morrison B., Knox E.G., Draper G.J., Miller A.B. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med. 5:1980;1-29.
15. Parkin D.M., Hodgson P., Clayden A.D. Incidence and prevalence of preclinical carcinoma of cervix in a British population. Br J Obstet Gynaecol. 89:1982;564-570.
16. Schwarz P.J., Fasal E., Simmons M.E. 12-County program Screening of 34,318 women for cervical cancer in California, 1975-78 . Public Health Rep. 96:1981;547-554.
17. Michielutte R., Dignan M.B., Wells H.B., Bahnson J., Smith M., Wooten R., et al. Errors in reporting cervical screening among public health clinic patients. J Clin Epidemiol. 44:1991;403-408.
18. Bottles K., Reiter R.C., Steiner A.L., Zaleski S., Bedrossian C.W.M., Johnson S.R. Problems encountered with the Bethesda System The University of Iowa experience . Obstet Gynecol. 78:1991;410-414.
19. Kaufman R.H. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion Diagnostic criteria and management . Am J Obstet Gynecol. 175:1996;1120-1128.
20. Davey D.D., Naryshkin S., Nielsen M.L., Klein T.S. Atypical squamous cells of undetermined significance Interlaboratory comparison and quality assurance monitors . Diagn Cytopathol. 11:1994;390-396.
21. Sweetnam P., Evans D., Hibbard B.M., Jones J.M. The Cardiff cervical cytology study Prevalence and epidemiology of cervical neoplasia . J Epidemiol Community Health. 35:1981;83-90.
22. Soost H.J., Bockmuhl B., Zock H. Results of cytologic mass screening in the Federal Republic of Germany. Acta Cytol. 26:1982;445-452.
23. Kirk R.S., Boon M.E. A comparison of efficiency of diagnosis of early cervical carcinoma by general practitioners and cytology screening programs in the Netherlands. Acta Cytol. 25:1981;259-262.
24. van der Graaf Y., Klinkhamer P.J., Vooijs G.P. Effect of population screening for cancer of the uterine cervix in Nijmegen, The Netherlands. Prev Med. 15:1986;582-590.
25. Boon M.E., de Graaf-Guilloud J.C. Cost effectiveness of population screening and rescreening for cervical cancer in the Netherlands. Acta Cytol. 25:1980;539-542.
26. Bjorge T., Gunbjorud A.B., Haugen O.A., Skare G.B., Trope C., Thoresen S.O. Mass screening for cervical cancer in Norway Evaluation of the pilot project . Cancer Causes Control. 6:1995;477-484.
27. Ostor A.G. Natural history of cervical intraepithelial neoplasia A critical review . Int J Gynecol Pathol. 12:1993;186-192.
28. Walker E.M., Dodgson J., Duncan I.D. Does mild atypia on a cervical smear warrant further investigation? Lancet. 2:1986;672-673.
29. Magnus K., Langmark F., Andersen A. Mass screening for cervical cancer in Ostfold County of Norway, 1959-1977. Int J Cancer. 39:1987;311-316.
30. Johannesson G., Geirsson G., Day N., Tulinius H. Screening for cancer of the uterine cervix in Iceland, 1965-1978. Acta Obstet Gynecol Scand. 61:1982;199-203.
31. MacCormac L., Lew W., King G., Allen P.W. Gynaecological cytology screening in South Australia A 23-year experience . Med J Aust. 149:1988;530-535.
32. Boon M.E., de Graaf Guilloud J.C., Kok L.P., Olthof P.M., van Erp E.J.M. Efficacy of screening for cervical squamous and adenocarcinoma The Dutch experience . Cancer. 59:1987;862-866.
33. Sigurdsson K., Adalsteinsson S., Hrafn T., Ragnarsson J. The value of screening as an approach to cervical cancer control in Iceland, 1964-1986. Int J Cancer. 43:1989;1-5.
34. Schwartz F.W., Brecht J.G. Evaluation of German cancer screening by cross-sectional data. Int J Epidemiol. 13:1984;283-286.
35. Kinlen L.J., Spriggs A.I. Women with positive cervical smears but without surgical intervention. A follow up study. Lancet. 2:1978;463-465.
36. Elwood J.M., Cotton R.E., Johnson J., Jones G.M., Curnow J., Beaver M.W. Are patients with abnormal cervical smears adequately managed? BMJ. 289:1984;891-894.